Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1874)	8/31/2007 12:48:13 AM
From: tnsaf	Read Replies (2) \| Respond to of 3722

Bernard, can you find anything in GILD's chart that is worth a comment? It has broken below its 200 day average, which it hasn't done since early 2005. It had looked like it might bounce along the top of the 200MA and be squeezed by the bottom of the 50MA to the upside, as has happened in the past. Jason

To: Jibacoa who wrote (1874)	1/14/2008 10:31:46 AM
From: Jibacoa	Respond to of 3722

SGEN opened with a DG & has been down 10% (about 9% at present) but is still holding above the $10 level.<g> bigcharts.marketwatch.com It announced today that it intends to offer to sell 10M shares of common with a 30-day option to the underwriters to purchase an additional 1.5M shares. As previously mentioned,SGEN has a pretty good pipeline.>g> SGN-40, which is developed in collaboration with DNA is in several trials for N-HL & MM. SGN-33 is in a PI for AML and MDS. SGN-35,an ADC, is in a PI for Hodgkin's. SGN-30 is in several PIIs sponsored by the NCI also for Hodgkin's & ALCL. SGN-70 is still in preclinical development. It seems SGEN should be able to close today's DG & after a close above $12 retest its Dec4 all time H at $13.44 bigcharts.marketwatch.com Bernard